Franklin Parlapiano Turner & Welch LLC Sells 89 Shares of The Procter & Gamble Company (NYSE:PG)

Franklin Parlapiano Turner & Welch LLC cut its holdings in The Procter & Gamble Company (NYSE:PG) by 0.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,622 shares of the company’s stock after selling 89 shares during the period. Procter & Gamble makes up 2.3% of Franklin Parlapiano Turner & Welch LLC’s portfolio, making the stock its 14th largest position. Franklin Parlapiano Turner & Welch LLC’s holdings in Procter & Gamble were worth $8,768,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the 2nd quarter valued at $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the second quarter worth about $29,000. Ruedi Wealth Management Inc. increased its holdings in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC bought a new position in Procter & Gamble during the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth approximately $36,000. 65.77% of the stock is owned by institutional investors.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 385,186 shares of company stock worth $65,479,358. Insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $169.58 on Thursday. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The business’s fifty day simple moving average is $171.88 and its two-hundred day simple moving average is $167.45. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The company has a market cap of $400.23 billion, a price-to-earnings ratio of 27.71, a P/E/G ratio of 3.72 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. During the same period last year, the company earned $1.83 EPS. Research analysts anticipate that The Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Analyst Ratings Changes

A number of brokerages recently commented on PG. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research note on Thursday, August 29th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research report on Monday. Citigroup boosted their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Evercore ISI raised their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday. Finally, TD Cowen initiated coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price on the stock. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.